5.2 Clinical Trials Participation in China

Accessing Innovation Through Structured Research

China has become a global powerhouse in clinical research, with a vast patient population and significant government investment. For international patients, participating in a clinical trial in China can provide access to the next generation of therapies (often from both Chinese and multinational pharma) that may not be available in their home country, frequently at little to no cost for the investigational treatment.

The Landscape: Phase III and "Innovator" Trials

• Late-Stage (Phase III) Global Trials: China is a key recruitment site for multinational Phase III trials. This gives patients access to drugs that are near approval in the US/EU.